New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and ...
Contributed by Jason Shull and Chris Galfano Innovation is the engine of the commercial drone industry. Advances in autonomy, ...
Propanc Biopharma, Inc. (Nasdaq: PPCB) is developing a novel approach to preventing cancer recurrence and metastasis by targeting and eradicating cancer stem cells through proenzyme activation. The ...
On Tuesday, patent data analytics firm IFI CLAIMS published its annual report of the top 50 U.S. patent recipients for 2025.
The newly filed intellectual property application is intended to protect a shoulder-mounted, multi-engagement non-lethal ...
U.S. Naloxone Market: ~$154 million in annual sales and 9.3 million units annuallyCOMMACK, NY, (GLOBE NEWSWIRE) -- SCIENTURE ...
ROSCREA, Ireland, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Renexxion Ireland Limited ("Renexxion"), a private biopharmaceutical company focused on advancing new therapies for patients with significant unmet ...
· Evenamide is a first-in-class glutamate modulator with a novel mechanism of action for patients who do not respond adequately, or are resistant to, existing antipsychotic therapies · ENIGMA-TRS ...
NAPLES, Fla. and CAMBRIDGE, United Kingdom - CDT Equity Inc. (NASDAQ:CDT) has engaged NJS Foresight Bio-Advisory, LLC to identify and execute out-licensing opportunities for selected assets within its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback